Kelly Kenzik1, I-Chan Huang, J Douglas Rizzo, Elizabeth Shenkman, John Wingard. 1. Center for Outcomes and Effectiveness Research and Education, Division of Preventive Medicine, School of Medicine, University of Alabama-Birmingham, MT521, Birmingham, AL, 35233, USA, kellykenzik@uabmc.edu.
Abstract
PURPOSE: The study aims to evaluate the mediating effect of depressive symptoms on the relationship between physical symptoms and health-related quality of life (HRQOL) in hematopoietic stem cell transplant (HSCT) survivors and to test a conceptual model of psychosocial factors, in addition to physical and psychological symptoms, that might contribute to HRQOL. METHODS: This is a secondary data analysis using HSCT survivors (N = 662) identified from the Center for International Blood and Marrow Transplant Research. Data were collected through mail and phone surveys and medical records. We used structural equation modeling to test the mediating role of depressive symptoms on the relationship of physical symptoms with HRQOL. We also tested comprehensive pathways from physical symptoms to HRQOL by adding psychosocial factors (optimism, coping, and social constraints). RESULTS: In the depressive symptom mediation analyses, physical symptoms had a stronger direct effect on physical HRQOL (b = -0.98, p < 0.001) than depressive symptoms (b = 0.23, p > 0.05). Depressive symptoms were associated with mental HRQOL and mediated the relationship between physical symptoms and mental HRQOL. In comprehensive pathways, physical symptoms remained the most significant factor associated with physical HRQOL. In contrast, depressive symptoms had direct effects (b = -0.76, p < 0.001) on mental HRQOL and were a significant mediator. Psychosocial factors were directly associated with mental HRQOL and indirectly associated with mental HRQOL through depressive symptoms. CONCLUSION: Physical symptoms are most strongly associated with physical HRQOL, while depressive symptoms and psychosocial factors impact mental HRQOL more than physical HRQOL. Interventions addressing psychosocial factors as well as symptoms may improve the HRQOL of HSCT survivors.
PURPOSE: The study aims to evaluate the mediating effect of depressive symptoms on the relationship between physical symptoms and health-related quality of life (HRQOL) in hematopoietic stem cell transplant (HSCT) survivors and to test a conceptual model of psychosocial factors, in addition to physical and psychological symptoms, that might contribute to HRQOL. METHODS: This is a secondary data analysis using HSCT survivors (N = 662) identified from the Center for International Blood and Marrow Transplant Research. Data were collected through mail and phone surveys and medical records. We used structural equation modeling to test the mediating role of depressive symptoms on the relationship of physical symptoms with HRQOL. We also tested comprehensive pathways from physical symptoms to HRQOL by adding psychosocial factors (optimism, coping, and social constraints). RESULTS: In the depressive symptom mediation analyses, physical symptoms had a stronger direct effect on physical HRQOL (b = -0.98, p < 0.001) than depressive symptoms (b = 0.23, p > 0.05). Depressive symptoms were associated with mental HRQOL and mediated the relationship between physical symptoms and mental HRQOL. In comprehensive pathways, physical symptoms remained the most significant factor associated with physical HRQOL. In contrast, depressive symptoms had direct effects (b = -0.76, p < 0.001) on mental HRQOL and were a significant mediator. Psychosocial factors were directly associated with mental HRQOL and indirectly associated with mental HRQOL through depressive symptoms. CONCLUSION: Physical symptoms are most strongly associated with physical HRQOL, while depressive symptoms and psychosocial factors impact mental HRQOL more than physical HRQOL. Interventions addressing psychosocial factors as well as symptoms may improve the HRQOL of HSCT survivors.
Authors: Stephanie J Lee; Fausto R Loberiza; J Douglas Rizzo; Robert J Soiffer; Joseph H Antin; Jane C Weeks Journal: Biol Blood Marrow Transplant Date: 2003-06 Impact factor: 5.742
Authors: Nicole Hochhausen; Elizabeth M Altmaier; Richard McQuellon; Stella M Davies; Esperanza Papadopolous; Shelly Carter; Jean Henslee-Downey Journal: J Psychosoc Oncol Date: 2007
Authors: Margaret F Bevans; Sandra A Mitchell; A John Barrett; Michael Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen Journal: Health Qual Life Outcomes Date: 2011-04-17 Impact factor: 3.186
Authors: Mohamad S Alabdaljabar; Ibrahim N Muhsen; Jennifer M Knight; Karen L Syrjala; Shahrukh K Hashmi Journal: Blood Rev Date: 2020-12-01 Impact factor: 8.250
Authors: I-Chan Huang; Melissa M Hudson; Leslie L Robison; Kevin R Krull Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-03-23 Impact factor: 4.254
Authors: Hermioni L Amonoo; Christina N Massey; Melanie E Freedman; Areej El-Jawahri; Halyna L Vitagliano; William F Pirl; Jeff C Huffman Journal: Psychosomatics Date: 2019-02-14 Impact factor: 2.386
Authors: Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2016-09-19 Impact factor: 5.742
Authors: Hsiu-Ju Yen; Hesham M Eissa; Neel S Bhatt; Sujuan Huang; Matthew J Ehrhardt; Nickhill Bhakta; Kirsten K Ness; Kevin R Krull; D Kumar Srivastava; Leslie L Robison; Melissa M Hudson; I-Chan Huang Journal: Blood Date: 2020-05-21 Impact factor: 22.113
Authors: I-Chan Huang; Tara M Brinkman; Gregory T Armstrong; Wendy Leisenring; Leslie L Robison; Kevin R Krull Journal: J Cancer Surviv Date: 2017-01-09 Impact factor: 4.442